about
Pattern of response of intact drosophila to known teratogensManagement of epilepsy in womenA clinical study of 57 children with fetal anticonvulsant syndromesValproic acid prenatal exposure. Association with lipomyelomeningoceleThe hazard evaluation system and information service: a physician's resource in toxicology and occupational medicine.Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.Potential reproductive and postnatal morbidity from exposure to polychlorinated biphenyls: epidemiologic considerationsTriphalangeal thumbDevelopmental neurotoxicity induced by therapeutic and illicit drugsClinical teratology.Increased sharing of maternal HLA haplotypes among children exposed to diphenylhydantoin during pregnancy.Fetal valproate syndrome.Maternal drug histories and congenital malformations: limb reduction defects and oral clefts.Cancer risk in persons with oral cleft--a population-based study of 8,093 cases.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Maternal alcohol use and risk of orofacial cleft birth defects.Prescribing in pregnancy. Epilepsy and anticonvulsant drugs.Teratogenic effects of antiepileptic drugsLaser light scan analysis of the "anticonvulsant face".Maternal factors, medications, and drug exposure in congenital limb reduction defects.Species sensitivities and prediction of teratogenic potential.Anticonvulsants in pregnancyAnti-epileptic drugs in pregnancy: current safety and other issues.Functional palatal incompetence in the fetal anticonvulsant syndromeLong term health and neurodevelopment in children exposed to antiepileptic drugs before birth.Fetal phenytoin exposure, hypoplastic nails, and jitterinessOtolaryngologic manifestations of phenytoin toxicity.Tetralogy of fallot and congenital connection between the left subclavian artery and the pulmonary artery: possible relationship to a congenital left-hand deformity.Safety of antiepileptic drugs during pregnancy.Risks of pregnancy in women with epilepsy.Reproductive counselling.Considering the Embryopathogenesis of VACTERL AssociationThe effects of pharmacological agents on the human fetus.Cognitive/behavioral teratogenetic effects of antiepileptic drugs.Intracranial haemorrhage in pregnancy.Vulnerability of macaque cranial nerve neurons to ethanol is time- and site-dependent.Teratogenicity of antiepileptic medications.Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects.Exposing fetal drug exposure.Teratogenic exposures.
P2860
Q23919791-AFA0EFCD-AE34-4389-8563-6B448BBB3B14Q24680158-BFD457B3-23D7-43C6-90C2-9179D15D8B16Q24681122-42C0A57B-53A6-4839-87AC-2CBA275361D2Q28340641-3C099960-4315-4B74-AF5C-2437618AF89CQ28367423-0025AE5E-56FD-48B3-8CB3-4CD2D34B13F8Q28378312-68D58910-4B67-4982-B483-3C2AB3E9AE08Q28390989-2F544838-6B87-452B-93E6-8C96556A953DQ28769838-26DA6773-0952-44A8-A312-7B1824331459Q30498465-D21BD3EC-C36E-4E83-9EFE-E36A3CE92791Q33581937-5E3C678C-4614-4AF2-B972-B9DA3D17B6C4Q33681960-9B968D10-A445-4369-AF80-A9C17499B465Q33682465-D43EDFD1-24C9-4BD8-B18B-BDC35B585D48Q33686645-C96F4849-E9BA-45F2-A831-F873121E9BE5Q33729995-D6B65A87-629A-4705-95DD-FD72B1B28936Q34047430-486EDD9E-F635-4B3D-BB2F-83A42147A155Q34063675-73CEE07C-15F1-40D9-AA07-46DB3EDBEDC8Q34068861-90B35E1E-5FB4-447A-9EDF-4C75B1AA6FCBQ34267151-BF7586C8-5354-4BC9-AC18-F96A64A0772BQ34580137-B82E2D28-2222-4622-AD03-B0911EE52D93Q34857730-29226066-A171-4EB9-989B-6A091DE54E2CQ35035971-9D394477-2E58-483F-B2FD-C802E1342C97Q35066660-ADF7439B-221C-4479-92FB-751AEABDFAE4Q35095179-6CC9C6A3-C09F-45B2-935E-3AFA054EDA56Q35118552-034C9455-29AF-44CF-AA2F-0E3F5C414D1EQ35439268-71F9F597-52F5-4A48-AD04-BEFFE67F2D95Q35626324-0B5FEB0D-AF03-4F05-9C6B-60D2BC6945F3Q36115849-66131285-3CC8-4993-BFFB-D5C9EFAE6543Q36156961-8CAA37F9-B3E7-4ACF-8E87-81407B259371Q36235506-549F5F2F-051D-402E-89C8-8293163F3628Q36379139-4AB0C8A3-F975-42AC-9A97-D30A2FDE4692Q36657233-2EAD85A1-4A84-4D32-BA56-ECE0879E6B54Q36802389-FC4A5FCC-82EB-49AF-AE8C-6A9438D51C07Q36923828-FB3AFD99-B628-474C-83B6-8FBB2DB6C531Q36998336-5057C584-6880-4AAC-A8D3-F4B6F689A48FQ37186063-F48D17D0-D8D6-4041-A43D-F2E418276DBEQ37251540-27B6BF1F-BDA5-427E-A1E8-7BDD5496942BQ37262946-448DF7C8-3E1B-49F2-AF75-3FF0A4EBDB48Q37537051-4D5230AF-CF71-4AFF-9641-8369F4A9521DQ37877128-276C5E62-4B68-48EA-B3ED-F83A4D4D4CE1Q37902128-A5E18641-991D-43E2-A1D1-A75C1C1D2631
P2860
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
The fetal hydantoin syndrome.
@en
The fetal hydantoin syndrome.
@nl
type
label
The fetal hydantoin syndrome.
@en
The fetal hydantoin syndrome.
@nl
prefLabel
The fetal hydantoin syndrome.
@en
The fetal hydantoin syndrome.
@nl
P1476
The fetal hydantoin syndrome.
@en
P2093
P304
P356
10.1016/S0022-3476(75)80604-4
P407
P577
1975-08-01T00:00:00Z